AGP Executive Report
Last update: 6 hours agoEuropean Supply: Cantourage and Canadian partner Green Karat are expanding their medical-cannabis partnership after Green Karat secured EU-GMP certification, a step intended to improve supply and add manufacturing capacity in Europe and the UK. CBD and Clinical Research: University of Regina researchers are studying CBD as a possible concussion treatment, while New York regulators approved a trial of THC oral solution for sciatica-related chronic pain. Patient Access: New Jersey signed reforms to expand access to its medicinal cannabis program; a new Maryland law also limits veterinary-board action against vets who discuss cannabis and CBD. Patient Experience: A survey found 80% of cancer patients reported symptom improvements with cannabis use, while a separate review linked cannabis products with sustained improvements in inflammatory arthritis. Both findings warrant careful interpretation, particularly as patient reports are not proof of treatment effectiveness.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
